Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 25, Issue 7, Pages 1096-1103
Publisher
Springer Science and Business Media LLC
Online
2019-07-02
DOI
10.1038/s41591-019-0495-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis
- (2019) Amandine Everard et al. Nature Communications
- Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy
- (2018) John M. Dennis et al. DIABETES CARE
- White blood cells count as an indicator to identify whether obesity leads to increased risk of type 2 diabetes
- (2018) Yeqing Gu et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Aberrant intestinal microbiota in individuals with prediabetes
- (2018) Kristine H. Allin et al. DIABETOLOGIA
- The Potential Role of the Dipeptidyl Peptidase-4-Like Activity From the Gut Microbiota on the Host Health
- (2018) Marta Olivares et al. Frontiers in Microbiology
- Akkermansia muciniphilainduces gut microbiota remodelling and controls islet autoimmunity in NOD mice
- (2017) Arno Hänninen et al. GUT
- Recovery of ethanol-inducedAkkermansia muciniphiladepletion ameliorates alcoholic liver disease
- (2017) Christoph Grander et al. GUT
- Effect of dipeptidyl peptidase-4 inhibitors on circulating tumor necrosis factor-α concentrations: A systematic review and meta-analysis of controlled trials
- (2017) Stephen L. Atkin et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- White blood cell subtypes and risk of type 2 diabetes
- (2017) Hongmei Zhang et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Quantitative microbiome profiling links gut community variation to microbial load
- (2017) Doris Vandeputte et al. NATURE
- Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
- (2017) Hao Wu et al. NATURE MEDICINE
- Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention
- (2017) Ruixin Liu et al. NATURE MEDICINE
- Dipeptidyl peptidase IV inhibitors as novel regulators of vascular disease
- (2017) Ioannis Akoumianakis et al. VASCULAR PHARMACOLOGY
- Protective Effect of Akkermansia muciniphila against Immune-Mediated Liver Injury in a Mouse Model
- (2017) Wenrui Wu et al. Frontiers in Microbiology
- Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila
- (2017) Patrice D. Cani et al. Frontiers in Microbiology
- Gut microbiota dysbiosis contributes to the development of hypertension
- (2017) Jing Li et al. Microbiome
- Low-Density Lipoprotein Receptor Signaling Mediates the Triglyceride-Lowering Action of Akkermansia muciniphila in Genetic-Induced HyperlipidemiaHighlights
- (2016) Jing Shen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Compositional analysis: a valid approach to analyze microbiome high-throughput sequencing data
- (2016) Gregory B. Gloor et al. CANADIAN JOURNAL OF MICROBIOLOGY
- Akkermansia MuciniphilaProtects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation inApoe−/−MiceCLINICAL PERSPECTIVE
- (2016) Jin Li et al. CIRCULATION
- A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice
- (2016) Hubert Plovier et al. NATURE MEDICINE
- DADA2: High-resolution sample inference from Illumina amplicon data
- (2016) Benjamin J Callahan et al. NATURE METHODS
- Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes
- (2016) Moran Yassour et al. Genome Medicine
- Akkermansia muciniphilaand improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology
- (2015) Maria Carlota Dao et al. GUT
- Specific gut microbiota features and metabolic markers in postmenopausal women with obesity
- (2015) L K Brahe et al. Nutrition & Diabetes
- Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies
- (2014) S. O'Neill et al. Obesity Reviews
- Efficacy and Safety of Lobeglitazone Monotherapy in Patients with Type 2 Diabetes Mellitus over 24-Weeks: A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo Controlled Trial
- (2014) Sin Gon Kim et al. PLoS One
- Consumption of plant sterol-enriched foods and effects on plasma plant sterol concentrations – A meta-analysis of randomized controlled studies
- (2013) Rouyanne T. Ras et al. ATHEROSCLEROSIS
- Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance
- (2013) Xiuying Zhang et al. PLoS One
- Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
- (2013) A. Everard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- White Blood Cells Count and Incidence of Type 2 Diabetes in Young Men
- (2012) G. Twig et al. DIABETES CARE
- Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation
- (2011) Mariann I. Lassenius et al. DIABETES CARE
- Elevated endotoxin levels in non-alcoholic fatty liver disease
- (2010) Alison L Harte et al. Journal of Inflammation-London
- Alanine Aminotransferase, -Glutamyltransferase, and Incident Diabetes: The British Women's Heart and Health Study and meta-analysis
- (2009) A. Fraser et al. DIABETES CARE
- Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
- (2009) Luca Miele et al. HEPATOLOGY
- Influence of assay-dependent variability of serum insulin levels on insulin sensitivity indices
- (2008) Dana Borza et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Efficacy and tolerability of vildagliptin in drug-nave patients with type 2 diabetes and mild hyperglycaemia
- (2008) W. A. Scherbaum et al. DIABETES OBESITY & METABOLISM
- Assay-dependent variability of serum insulin levels during oral glucose tolerance test: influence on reference intervals for insulin and on cut-off values for insulin sensitivity indices
- (2007) Maria Werner et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started